top of page

Dr. McIntyre comments on GLP-1 Agonists for psychiatry on HCP Live

Dr. Roger McIntyre explains why GLP-1/GIP receptor agonists like semaglutide may alter cognitive and psychiatric care similar to cardiometabolic disease.

Image-empty-state.png

MAY, 5 2024

Research included in cnet article

Research on COVID-19 included in cnet article.

Image-empty-state.png

MAR, 09, 2022

Research featured in PsyPost

Dr. Roger McIntyre discusses COVID-19

Image-empty-state.png

FEB, 03, 2022

Research included in Daily Mail article.

Research on COVID-19 included in Daily Mail article.

Image-empty-state.png

JAN, 13, 2022

Research featured in The Record

Research on COVID-19 included in The Record article.

Image-empty-state.png

JAN, 08, 2022

Research included in New Atlas article.

Research on COVID-19 included in New Atlas article.

Image-empty-state.png

JAN, 06, 2022

Dr. Roger McIntyre interviewed on CBC

Dr. Roger McIntyre discusses the impact of long-term stress on our brains in light of the pandemic.

Image-empty-state.png

APR, 12, 2021

Research conducted by Dr. McIntyre about the impact of COVID-19 on brain health is featured on CBC

A review co-authored by Dr. McIntyre about cognitive impairment in patients with COVID-19 is discussed.

Image-empty-state.png

APR, 01, 2021

Dr. Roger McIntyre featured interview with PsychFocus

Dr. Roger McIntyre discusses his new paper addressing the current state of bipolar disorder with PsychFocus.

Image-empty-state.png

FEB, 8, 2021

bottom of page